Affordable Inhalers and Nebulizers Act of 2025

This bill, S 2756 (Affordable Inhalers and Nebulizers Act of 2025), sets a $15 monthly cost cap for specified inhaler products used to treat asthma and COPD under private insurance, Medicare Part B, and Medicare Part D plans. It requires insurers to cover these products without deductibles and counts any cost-sharing toward the annual out-of-pocket maximum. The bill also creates a new program to pay for these products for uninsured individuals starting in 2026, with providers agreeing not to bill patients more than $15 per month. It directly affects patients with asthma or COPD who rely on prescribed inhalers or nebulizers, ensuring predictable, low-cost access to these essential treatments.